Clinical Cancer Research Research Funding
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
[Cover Caption]
Other Issues:
Contents: May 1 2005, Volume 11, Issue 9   [Index by Author] 
    The Biology Behind
    Reviews
    Human Cancer Biology
    Imaging, Diagnosis, Prognosis
    Cancer Therapy: Clinical
    Cancer Therapy: Preclinical
    Cancer Prevention
    Letters to the Editor
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

The Biology Behind:

Transforming Growth Factor-ß, Smads, and Cancer
William M. Grady
Clin Cancer Res 2005 11: 3151-3154. [Full Text] [PDF]  

Reviews:

Cell Death Independent of Caspases: A Review
Linda E. Bröker, Frank A.E. Kruyt, and Giuseppe Giaccone
Clin Cancer Res 2005 11: 3155-3162. [Abstract] [Full Text] [PDF]  

Mining the Tumor Phosphoproteome for Cancer Markers
Yoon Pin Lim
Clin Cancer Res 2005 11: 3163-3169. [Abstract] [Full Text] [PDF]  

Human Cancer Biology:

Increased Estrogen Receptor ßcx Expression during Mammary Carcinogenesis
Majida Esslimani-Sahla, Andrew Kramar, Joelle Simony-Lafontaine, Margaret Warner, Jan-Åke Gustafsson, and Henri Rochefort
Clin Cancer Res 2005 11: 3170-3174. [Abstract] [Full Text] [PDF]  

Ferritin Contributes to Melanoma Progression by Modulating Cell Growth and Sensitivity to Oxidative Stress
Alfonso Baldi, Daniela Lombardi, Patrizia Russo, Emanuele Palescandolo, Antonio De Luca, Daniele Santini, Feliciano Baldi, Luigi Rossiello, Maria Lucia Dell'Anna, Arianna Mastrofrancesco, Vittoria Maresca, Enrica Flori, Pier Giorgio Natali, Mauro Picardo, and Marco G. Paggi
Clin Cancer Res 2005 11: 3175-3183. [Abstract] [Full Text] [PDF]  

Down-Regulation and Growth Inhibitory Role of C/EBP{alpha} in Breast Cancer
Sigal Gery, Sakae Tanosaki, Shikha Bose, Namrata Bose, Jay Vadgama, and H. Phillip Koeffler
Clin Cancer Res 2005 11: 3184-3190. [Abstract] [Full Text] [PDF]  

Differences in Smad4 Expression in Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Squamous Cell Carcinoma
Adriana Báez, Alan Cantor, Sharon Fonseca, Maria Marcos-Martinez, Linda A. Mathews, Carlos A. Muro-Cacho, and Teresita Muñoz-Antonia
Clin Cancer Res 2005 11: 3191-3197. [Abstract] [Full Text] [PDF]  

Imaging, Diagnosis, Prognosis:

Int6 Expression Can Predict Survival in Early-Stage Non–Small Cell Lung Cancer Patients
Fiamma Buttitta, Carla Martella, Fabio Barassi, Lara Felicioni, Simona Salvatore, Sandra Rosini, Tommaso D'Antuono, Antonio Chella, Felice Mucilli, Rocco Sacco, Andrea Mezzetti, Franco Cuccurullo, Robert Callahan, and Antonio Marchetti
Clin Cancer Res 2005 11: 3198-3204. [Abstract] [Full Text] [PDF]  

Serum Human Telomerase Reverse Transcriptase Messenger RNA as a Novel Tumor Marker for Hepatocellular Carcinoma
Norimasa Miura, Yoshiko Maeda, Takamasa Kanbe, Hiroaki Yazama, Yohei Takeda, Reina Sato, Tomoe Tsukamoto, Emi Sato, Akira Marumoto, Tomomi Harada, Akiko Sano, Yosuke Kishimoto, Yasuaki Hirooka, Yoshikazu Murawaki, Junichi Hasegawa, and Goshi Shiota
Clin Cancer Res 2005 11: 3205-3209. [Abstract] [Full Text] [PDF]  

Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy
Michael J. Morris, Timothy Akhurst, Steven M. Larson, Marisa Ditullio, Elaina Chu, Karen Siedlecki, David Verbel, Glenn Heller, W. Kevin Kelly, Susan Slovin, Lawrence Schwartz, and Howard I. Scher
Clin Cancer Res 2005 11: 3210-3216. [Abstract] [Full Text] [PDF]  

Activation of the RAS Pathway Is Predictive for a Chemosensitive Phenotype of Acute Myelogenous Leukemia Blasts
Thomas Illmer, Christian Thiede, Anke Fredersdorf, Sylvia Stadler, Andreas Neubauer, Gerhard Ehninger, and Markus Schaich
Clin Cancer Res 2005 11: 3217-3224. [Abstract] [Full Text] [PDF]  

Vascular Endothelial Growth Factor-C Expression and Invasive Phenotype in Ovarian Carcinomas
Masatsugu Ueda, Yao-Ching Hung, Yoshito Terai, Koji Kanda, Masanori Kanemura, Hikari Futakuchi, Hiroyuki Yamaguchi, Daisuke Akise, Masayuki Yasuda, and Minoru Ueki
Clin Cancer Res 2005 11: 3225-3232. [Abstract] [Full Text] [PDF]  

Increased Expression of Insulin-Like Growth Factor I and/or Its Receptor in Gastrinomas Is Associated with Low Curability, Increased Growth, and Development of Metastases
Masayuki Furukawa, Mark Raffeld, Carmen Mateo, Akio Sakamoto, Terry W. Moody, Tetsuhide Ito, David J. Venzon, Jose Serrano, and Robert T. Jensen
Clin Cancer Res 2005 11: 3233-3242. [Abstract] [Full Text] [PDF]  

Noninvasive Detection of Prostate Cancer by Quantitative Analysis of Telomerase Activity
Galina I. Botchkina, Roger H. Kim, Inna L. Botchkina, Alex Kirshenbaum, Zelik Frischer, and Howard L. Adler
Clin Cancer Res 2005 11: 3243-3249. [Abstract] [Full Text] [PDF]  

Cyclooxygenase-2 Expression Correlates with Local Chronic Inflammation and Tumor Neovascularization in Human Prostate Cancer
Wanzhong Wang, Anders Bergh, and Jan-Erik Damber
Clin Cancer Res 2005 11: 3250-3256. [Abstract] [Full Text] [PDF]  

Tissue Inhibitor of Matrix Metalloproteinase-1 Is Prognostic in Head and Neck Squamous Cell Carcinoma: Comparison of the Circulating and Tissue Immunoreactive Protein
Henni Ruokolainen, Paavo Pääkkö, and Taina Turpeenniemi-Hujanen
Clin Cancer Res 2005 11: 3257-3264. [Abstract] [Full Text] [PDF]  

Expression of Cell Cycle–Regulated Proteins pRB2/p130, p107, E2F4, p27, and pCNA in Salivary Gland Tumors: Prognostic and Diagnostic Implications
Giuseppe Russo, Alessandra Zamparelli, Candace M. Howard, Corrado Minimo, Cristiana Bellan, Giovanna Carillo, Luigi Califano, Lorenzo Leoncini, Antonio Giordano, and Pier Paolo Claudio
Clin Cancer Res 2005 11: 3265-3273. [Abstract] [Full Text] [PDF]  

14-3-3{sigma} Expression Is an Independent Prognostic Parameter for Poor Survival in Colorectal Carcinoma Patients
Alexander Perathoner, Daniela Pirkebner, Gerald Brandacher, Gilbert Spizzo, Sylvia Stadlmann, Peter Obrist, Raimund Margreiter, and Albert Amberger
Clin Cancer Res 2005 11: 3274-3279. [Abstract] [Full Text] [PDF]  

Shc Family Expression in Neuroblastoma: High Expression of shcC Is Associated with a Poor Prognosis in Advanced Neuroblastoma
Elena Terui, Tadashi Matsunaga, Hideo Yoshida, Katsunori Kouchi, Hiroaki Kuroda, Tomoro Hishiki, Takeshi Saito, Shin-ichi Yamada, Hiroshi Shirasawa, and Naomi Ohnuma
Clin Cancer Res 2005 11: 3280-3287. [Abstract] [Full Text] [PDF]  

Metabotropic Glutamate Receptor 4 Expression in Colorectal Carcinoma and Its Prognostic Significance
Hee Jin Chang, Byong Chul Yoo, Seok-Byung Lim, Seung-Yong Jeong, Woo Ho Kim, and Jae-Gahb Park
Clin Cancer Res 2005 11: 3288-3295. [Abstract] [Full Text] [PDF]  

Drg1 Expression in 131 Colorectal Liver Metastases: Correlation with Clinical Variables and Patient Outcomes
Manish A. Shah, Nancy Kemeny, Amanda Hummer, Marija Drobnjak, Monica Motwani, Carlos Cordon-Cardo, Mithat Gonen, and Gary K. Schwartz
Clin Cancer Res 2005 11: 3296-3302. [Abstract] [Full Text] [PDF]  

P16 Loss and Mitotic Activity Predict Poor Survival in Patients with Peritoneal Malignant Mesothelioma
Alain C. Borczuk, Robert N. Taub, Mary Hesdorffer, Hanina Hibshoosh, John A. Chabot, Mary L. Keohan, Ritchie Alsberry, Diane Alexis, and Charles A. Powell
Clin Cancer Res 2005 11: 3303-3308. [Abstract] [Full Text] [PDF]  

CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma
Leslie K. Diaz, Xiao Zhou, Edward T. Wright, Massimo Cristofanilli, Terry Smith, Ying Yang, Nour Sneige, Aysegul Sahin, and Michael Z. Gilcrease
Clin Cancer Res 2005 11: 3309-3314. [Abstract] [Full Text] [PDF]  

Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy
Francisco J. Esteva, Aysegul A. Sahin, Massimo Cristofanilli, Kevin Coombes, Sang-Joon Lee, Joffre Baker, Maureen Cronin, Michael Walker, Drew Watson, Steven Shak, and Gabriel N. Hortobagyi
Clin Cancer Res 2005 11: 3315-3319. [Abstract] [Full Text] [PDF]  

Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer
Alessandro D. Santin, Eleftherios P. Diamandis, Stefania Bellone, Antoninus Soosaipillai, Stefania Cane, Michela Palmieri, Alexander Burnett, Juan J. Roman, and Sergio Pecorelli
Clin Cancer Res 2005 11: 3320-3325. [Abstract] [Full Text] [PDF]  

YKL-40 Expression is Associated with Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma
Christopher E. Pelloski, Anita Mahajan, Moshe Maor, Eric L. Chang, Shiao Woo, Mark Gilbert, Howard Colman, Helen Yang, Alicia Ledoux, Hilary Blair, Sandra Passe, Robert B. Jenkins, and Kenneth D. Aldape
Clin Cancer Res 2005 11: 3326-3334. [Abstract] [Full Text] [PDF]  

Cancer Therapy: Clinical:

Phase I Study of a Novel Taxane BMS-188797 in Adult Patients with Solid Malignancies
Christopher R. Garrett, Mayer N. Fishman, Randall R. Rago, Charles C. Williams, Anne M. Dellaportas, J. Joseph Mahany, Richard M. Lush, William S. Dalton, Ashwin Gollerkeri, Marvin B. Cohen, and Daniel M. Sullivan
Clin Cancer Res 2005 11: 3335-3341. [Abstract] [Full Text] [PDF]  

A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer
Zhongxing Liao, Ritsuko Komaki, Luka Milas, Chen Yuan, Merrill Kies, Joe Y. Chang, Melenda Jeter, Thomas Guerrero, George Blumenschien, Cheryl M. Smith, Frank Fossella, Barry Brown, and James D. Cox
Clin Cancer Res 2005 11: 3342-3348. [Abstract] [Full Text] [PDF]  

High Relapse Rate in Patients with MALT Lymphoma Warrants Lifelong Follow-up
Markus Raderer, Berthold Streubel, Stefan Woehrer, Andreas Puespoek, Ulrich Jaeger, Michael Formanek, and Andreas Chott
Clin Cancer Res 2005 11: 3349-3352. [Abstract] [Full Text] [PDF]  

Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer
James L. Gulley, Philip M. Arlen, Anne Bastian, Steven Morin, Jennifer Marte, Patricia Beetham, Kwong-Yok Tsang, Junko Yokokawa, James W. Hodge, Cynthia Ménard, Kevin Camphausen, C. Norman Coleman, Francis Sullivan, Seth M. Steinberg, Jeffrey Schlom, and William Dahut
Clin Cancer Res 2005 11: 3353-3362. [Abstract] [Full Text] [PDF]  

Intratumoral COX-2 Gene Expression Is a Predictive Factor for Colorectal Cancer Response to Fluoropyrimidine-Based Chemotherapy
Kazumi Uchida, Sylke Schneider, Ji Min Yochim, Hidekazu Kuramochi, Kazuhiko Hayashi, Ken Takasaki, Dongyun Yang, Kathleen D. Danenberg, and Peter V. Danenberg
Clin Cancer Res 2005 11: 3363-3368. [Abstract] [Full Text] [PDF]  

A Multicenter Phase II Trial of ZD6474, a Vascular Endothelial Growth Factor Receptor-2 and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Previously Treated Metastatic Breast Cancer
Kathy D. Miller, Jose Manuel Trigo, Catherine Wheeler, Alan Barge, Jacqui Rowbottom, George Sledge, and Jose Baselga
Clin Cancer Res 2005 11: 3369-3376. [Abstract] [Full Text] [PDF]  

Generation of Potent Antitumor CTL from Patients with Multiple Myeloma Directed against HM1.24
Steven B. Rew, Karl Peggs, Irene Sanjuan, Arnold R. Pizzey, Yasuo Koishihara, Shigeto Kawai, Masaaki Kosaka, Shuji Ozaki, Benjamin Chain, and Kwee L. Yong
Clin Cancer Res 2005 11: 3377-3384. [Abstract] [Full Text] [PDF]  

Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients with Refractory Advanced Cancers
Ramesh K. Ramanathan, Donald L. Trump, Julie L. Eiseman, Chandra P. Belani, Sanjiv S. Agarwala, Eleanor G. Zuhowski, Jing Lan, Douglas M. Potter, S. Percy Ivy, Sakkaraiappan Ramalingam, Adam M. Brufsky, Michael K.K. Wong, Susan Tutchko, and Merrill J. Egorin
Clin Cancer Res 2005 11: 3385-3391. [Abstract] [Full Text] [PDF]  

Enhanced Pharmacodynamic and Antitumor Properties of a Histone Deacetylase Inhibitor Encapsulated in Liposomes or ErbB2-Targeted Immunoliposomes
Daryl C. Drummond, Corina Marx, Zexiong Guo, Gary Scott, Charles Noble, Donghui Wang, Maria Pallavicini, Dmitri B. Kirpotin, and Christopher C. Benz
Clin Cancer Res 2005 11: 3392-3401. [Abstract] [Full Text] [PDF]  

Temozolomide Pharmacodynamics in Patients with Metastatic Melanoma: DNA Damage and Activity of Repair Enzymes O6-Alkylguanine Alkyltransferase and Poly(ADP-Ribose) Polymerase-1
E. Ruth Plummer, Mark R. Middleton, Christopher Jones, Anna Olsen, Ian Hickson, Peter McHugh, Geoffrey P. Margison, Gail McGown, Mary Thorncroft, Amanda J. Watson, Alan V. Boddy, A. Hilary Calvert, Adrian L. Harris, David R. Newell, and Nicola J. Curtin
Clin Cancer Res 2005 11: 3402-3409. [Abstract] [Full Text] [PDF]  

A Phase I and Pharmacologic Trial of Two Schedules of the Proteasome Inhibitor, PS-341 (Bortezomib, Velcade), in Patients with Advanced Cancer
Grace K. Dy, James P. Thomas, George Wilding, Laura Bruzek, Sumithra Mandrekar, Charles Erlichman, Dona Alberti, Kim Binger, Henry C. Pitot, Steven R. Alberts, Lorelei J. Hanson, Rebecca Marnocha, Kendra Tutsch, Scott H. Kaufmann, and Alex A. Adjei
Clin Cancer Res 2005 11: 3410-3416. [Abstract] [Full Text] [PDF]  

Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer
John R. Goffin, Ian C. Anderson, Jeffrey G. Supko, Joseph Paul Eder, Jr., Geoffrey I. Shapiro, Thomas J. Lynch, Margaret Shipp, Bruce E. Johnson, and Arthur T. Skarin
Clin Cancer Res 2005 11: 3417-3424. [Abstract] [Full Text] [PDF]  

Molecular Responses in Patients with Chronic Myelogenous Leukemia in Chronic Phase Treated with Imatinib Mesylate
Jorge Cortes, Moshe Talpaz, Susan O'Brien, Dan Jones, Rajyalakshmi Luthra, Jenny Shan, Francis Giles, Stefan Faderl, Srdan Verstovsek, Guillermo Garcia-Manero, Mary B. Rios, and Hagop Kantarjian
Clin Cancer Res 2005 11: 3425-3432. [Abstract] [Full Text] [PDF]  

Cancer Therapy: Preclinical:

RNA Interference Demonstrates a Novel Role for Integrin-Linked Kinase as a Determinant of Pancreatic Adenocarcinoma Cell Gemcitabine Chemoresistance
Mark S. Duxbury, Hiromichi Ito, Eric Benoit, Talat Waseem, Stanley W. Ashley, and Edward E. Whang
Clin Cancer Res 2005 11: 3433-3438. [Abstract] [Full Text] [PDF]  

Resistance to the Tubulin-Binding Agents in Renal Cell Carcinoma: No Mutations in the Class I ß-Tubulin Gene but Changes in Tubulin Isotype Protein Expression
Roisean E. Ferguson, Claire Taylor, Anthea Stanley, Elizabeth Butler, Adrian Joyce, Patricia Harnden, Poulam M. Patel, Peter J. Selby, and Rosamonde E. Banks
Clin Cancer Res 2005 11: 3439-3445. [Abstract] [Full Text] [PDF]  

Definition of an Immunogenic Region Within the Ovarian Tumor Antigen Stratum Corneum Chymotryptic Enzyme
Kristina L. Bondurant, Mark D. Crew, Alessandro D. Santin, Timothy J. O'Brien, and Martin J. Cannon
Clin Cancer Res 2005 11: 3446-3454. [Abstract] [Full Text] [PDF]  

Antimetastatic Effect of Salvicine on Human Breast Cancer MDA-MB-435 Orthotopic Xenograft Is Closely Related to Rho-Dependent Pathway
Jing-Yu Lang, Hua Chen, Jin Zhou, Yi-Xiang Zhang, Xiong-Wen Zhang, Mei-Hong Li, Li-Ping Lin, Jin-Sheng Zhang, Michael P. Waalkes, and Jian Ding
Clin Cancer Res 2005 11: 3455-3464. [Abstract] [Full Text] [PDF]  

Systemic Delivery of Liposomal Short-Chain Ceramide Limits Solid Tumor Growth in Murine Models of Breast Adenocarcinoma
Thomas C. Stover, Arati Sharma, Gavin P. Robertson, and Mark Kester
Clin Cancer Res 2005 11: 3465-3474. [Abstract] [Full Text] [PDF]  

The Antitumor Effects of Angelica sinensis on Malignant Brain Tumors In vitro and In vivo
Nu-Man Tsai, Shinn-Zong Lin, Chau-Chin Lee, Shee-Ping Chen, Hsuan-Chi Su, Wen-Liang Chang, and Horng-Jyh Harn
Clin Cancer Res 2005 11: 3475-3484. [Abstract] [Full Text] [PDF]  

Sensitivity to Gemcitabine and Its Metabolizing Enzymes in Neuroblastoma
Masahiro Ogawa, Hiroki Hori, Takuya Ohta, Kaori Onozato, Masazumi Miyahara, and Yoshihiro Komada
Clin Cancer Res 2005 11: 3485-3493. [Abstract] [Full Text] [PDF]  

Blockade of Paracrine Supply of Insulin-Like Growth Factors Using Neutralizing Antibodies Suppresses the Liver Metastasis of Human Colorectal Cancers
Shin'ichi Miyamoto, Michio Nakamura, Kenya Shitara, Kazuyasu Nakamura, Yuji Ohki, Genichiro Ishii, Masato Goya, Keiji Kodama, Takafumi Sangai, Hiroyuki Maeda, Zhang Shi-chuang, Tsutomu Chiba, and Atsushi Ochiai
Clin Cancer Res 2005 11: 3494-3502. [Abstract] [Full Text] [PDF]  

Metabolic Signatures Associated with a NAD Synthesis Inhibitor–Induced Tumor Apoptosis Identified by 1H-Decoupled-31P Magnetic Resonance Spectroscopy
Manickam Muruganandham, Alan A. Alfieri, Cornelia Matei, Yuchun Chen, George Sukenick, Isabel Schemainda, Max Hasmann, Leonard B. Saltz, and Jason A. Koutcher
Clin Cancer Res 2005 11: 3503-3513. [Abstract] [Full Text] [PDF]  

Differential Effects of Vascular Endothelial Growth Factor Receptor-2 Inhibitor ZD6474 on Circulating Endothelial Progenitors and Mature Circulating Endothelial Cells: Implications for Use as a Surrogate Marker of Antiangiogenic Activity
Paul Beaudry, Jeremy Force, George N. Naumov, Andrew Wang, Cheryl H. Baker, Anderson Ryan, Shay Soker, Bruce E. Johnson, Judah Folkman, and John V. Heymach
Clin Cancer Res 2005 11: 3514-3522. [Abstract] [Full Text] [PDF]  

Flavopiridol Sensitivity of Cancer Cells Isolated from Ascites and Pleural Fluids
Christina Richard, Donald Matthews, Wilhelmina Duivenvoorden, Jonathan Yau, Paul S. Wright, and John P.H. Th'ng
Clin Cancer Res 2005 11: 3523-3529. [Abstract] [Full Text] [PDF]  

Antiangiogenic Properties of Gold Nanoparticles
Priyabrata Mukherjee, Resham Bhattacharya, Ping Wang, Ling Wang, Sujit Basu, Janice A. Nagy, Anthony Atala, Debabrata Mukhopadhyay, and Shay Soker
Clin Cancer Res 2005 11: 3530-3534. [Abstract] [Full Text] [PDF]  

Epigenetic Modulation of Retinoic Acid Receptor ß2 by the Histone Deacetylase Inhibitor MS-275 in Human Renal Cell Carcinoma
Xiao-fei Wang, David Z. Qian, Mingqiang Ren, Yukihiko Kato, Yongfeng Wei, Lu Zhang, Zoya Fansler, Doug Clark, Osamu Nakanishi, and Roberto Pili
Clin Cancer Res 2005 11: 3535-3542. [Abstract] [Full Text] [PDF]  

Noninvasive Monitoring of Murine Tumor Blood Flow During and After Photodynamic Therapy Provides Early Assessment of Therapeutic Efficacy
Guoqiang Yu, Turgut Durduran, Chao Zhou, Hsing-Wen Wang, Mary E. Putt, H. Mark Saunders, Chandra M. Sehgal, Eli Glatstein, Arjun G. Yodh, and Theresa M. Busch
Clin Cancer Res 2005 11: 3543-3552. [Abstract] [Full Text] [PDF]  

Reduction of Intracellular pH as a Strategy to Enhance the pH-Dependent Cytotoxic Effects of Melphalan for Human Breast Cancer Cells
Philip Wong, Carol Lee, and Ian F. Tannock
Clin Cancer Res 2005 11: 3553-3557. [Abstract] [Full Text] [PDF]  

Retinoic Acid and the Histone Deacetylase Inhibitor Trichostatin A Inhibit the Proliferation of Human Renal Cell Carcinoma in a Xenograft Tumor Model
Sue Ellen Touma, Jonathan S. Goldberg, Paul Moench, Xiaojia Guo, Satish K. Tickoo, Lorraine J. Gudas, and David M. Nanus
Clin Cancer Res 2005 11: 3558-3566. [Abstract] [Full Text] [PDF]  

Anti-CD19-Targeted Liposomal Doxorubicin Improves the Therapeutic Efficacy in Murine B-Cell Lymphoma and Ameliorates the Toxicity of Liposomes with Varying Drug Release Rates
Theresa M. Allen, Davis R. Mumbengegwi, and Gregory J.R. Charrois
Clin Cancer Res 2005 11: 3567-3573. [Abstract] [Full Text] [PDF]  

Combined Liposome-Mediated Cytosine Deaminase Gene Therapy with Radiation in Killing Rectal Cancer Cells and Xenografts in Athymic Mice
Shiyong Li, Bo Yu, Ping An, Gang Chen, Wenping Lu, Huiyun Cai, Wenhua Guo, and Fuyi Zuo
Clin Cancer Res 2005 11: 3574-3578. [Abstract] [Full Text] [PDF]  

Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue
Kelly Townsend, Claire M. Banwell, Michelle Guy, Kay W. Colston, Janine L. Mansi, Paul M. Stewart, Moray J. Campbell, and Martin Hewison
Clin Cancer Res 2005 11: 3579-3586. [Abstract] [Full Text] [PDF]  

Cancer Prevention:

Expression of HOXB2, a Retinoic Acid Signaling Target in Pancreatic Cancer and Pancreatic Intraepithelial Neoplasia
Davendra Segara, Andrew V. Biankin, James G. Kench, Catherine C. Langusch, Amanda C. Dawson, David A. Skalicky, David C. Gotley, Maxwell J. Coleman, Robert L. Sutherland, and Susan M. Henshall
Clin Cancer Res 2005 11: 3587-3596. [Abstract] [Full Text] [PDF]  

Letters to the Editor:

Growth and Molecular Interactions between Tamoxifen and Trastuzumab
Alejandro Vázquez-Martín, Ramon Colomer, Santiago Ropero, Javier Abel Menéndez, Athanassios Argiris, Chun-Xia Wang, Debbie C. Koay, and Michael P. DiGiovanna
Clin Cancer Res 2005 11: 3597. [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.